Biochemistry Quiz: Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed

20 questions · exam conditions

0:00

Enzyme Inhibition Competitive Noncompetitive Uncompetitive MixedQuestion 1 of 20

An investigator is attempting to distinguish between a competitive inhibitor and a mixed inhibitor that increases the apparent $K_m$ . Both inhibitors are tested at concentrations that yield 50% inhibition at a substrate concentration equal to $K_m$ . Which experimental approach would most clearly differentiate the two inhibitor types?

Measure the reaction velocity at a saturating substrate concentration in the presence of each inhibitor.

Determine the chemical structure of each inhibitor to see if it resembles the substrate.

Use equilibrium dialysis to measure the dissociation constant (

K_I

) for each inhibitor.

Perform the assay at a different pH to see if the inhibitor's binding is affected.

← Back to quizzes

Biochemistry Quiz

Biochemistry Quiz: Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed

Practice Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed in Biochemistry with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Enzyme Inhibition Competitive Noncompetitive Uncompetitive Mixed, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Measure the reaction velocity at a saturating substrate concentration in the presence of each inhibitor. (correct answer)
Determine the chemical structure of each inhibitor to see if it resembles the substrate.
Use equilibrium dialysis to measure the dissociation constant ( $K_I$ ) for each inhibitor.
Perform the assay at a different pH to see if the inhibitor's binding is affected.

Explanation: The key difference is their effect at saturating substrate concentration. The inhibition by a competitive inhibitor can be completely overcome by a sufficiently high concentration of substrate, so the reaction velocity will approach the uninhibited

V_{max}

. A mixed inhibitor, however, lowers the apparent

V_{max}

, so even at saturating substrate concentrations, the reaction will be slower than the uninhibited

V_{max}

. Measuring the rate at saturating [S] provides the most definitive distinction.

Question 2

An enzyme is inhibited by a compound that binds to a site distinct from the substrate binding site. This binding event reduces the enzyme's catalytic turnover number but also leads to a decrease in the apparent $K_m$ . This inhibitor is best classified as:

An uncompetitive inhibitor that binds only to the enzyme-substrate complex. (correct answer)
A competitive inhibitor that allosterically alters the active site.
A pure noncompetitive inhibitor that affects catalysis but not binding.
An irreversible inhibitor that covalently modifies the enzyme.

Explanation: The key observations are: (1) binding to a site distinct from the substrate binding site (allosteric), (2) reduced catalytic turnover (decreased

V_{max}

), and (3) decreased apparent

K_m

. The combination of decreased

V_{max}

and decreased apparent

K_m

is the specific kinetic signature of uncompetitive inhibition, where the inhibitor binds only to the ES complex. This binding stabilizes the ES complex, effectively increasing the apparent affinity for substrate (lower

K_m

) while preventing productive catalysis (lower

V_{max}

Question 3

A researcher compares two competitive inhibitors, Inhibitor X ( $K_I = 10 \mu M$ ) and Inhibitor Y ( $K_I = 20 \mu M$ ). The enzyme's $K_m$ for its substrate is 5 $\mu M$ . If both inhibitors are present at a concentration of 10 $\mu M$ , which statement is correct?

Inhibitor Y will be more effective because its $K_I$ is higher than that of Inhibitor X.
Inhibitor X will cause a larger increase in the apparent $K_m$ than Inhibitor Y. (correct answer)
Both inhibitors will increase the apparent $K_m$ to the same value because they are at the same concentration.
Neither inhibitor will have a significant effect, as their concentrations are equal to or less than their $K_I$ values.

Explanation: When you encounter competitive inhibition problems, focus on how inhibitors affect the apparent

K_m

based on their binding affinity (

K_I

) and concentration. For competitive inhibition, the apparent

K_m

increases according to:

K_m^{app} = K_m(1 + \frac{[I]}{K_I})

Let's calculate the apparent

K_m

for each inhibitor at 10 μM concentration: For Inhibitor X:

K_m^{app} = 5(1 + \frac{10}{10}) = 5(1 + 1) = 10 \text{ μM}

For Inhibitor Y:

K_m^{app} = 5(1 + \frac{10}{20}) = 5(1 + 0.5) = 7.5 \text{ μM}

Inhibitor X causes a larger increase in apparent

K_m

(from 5 to 10 μM) compared to Inhibitor Y (from 5 to 7.5 μM), confirming answer B is correct. Answer A is wrong because lower

K_I

values indicate stronger binding and greater inhibitory effectiveness, not higher values. Answer C incorrectly assumes that equal inhibitor concentrations produce equal effects—the

K_I

values determine the relative effectiveness. Answer D is incorrect because both inhibitors have significant effects; the concentration doesn't need to exceed

K_I

to cause inhibition. Study tip: Remember that competitive inhibition effectiveness depends on the ratio

\frac{[I]}{K_I}

. Lower

K_I

means stronger binding, so always compare this ratio rather than just concentrations or

K_I

values alone.

Question 4

The drug methotrexate is a structural analog of dihydrofolate and inhibits the enzyme dihydrofolate reductase. It binds to the enzyme's active site with an affinity nearly 1000-fold higher than the natural substrate. Kinetically, increasing the concentration of dihydrofolate can eventually restore the maximal reaction velocity. Methotrexate is best described as which type of inhibitor?

A classic noncompetitive inhibitor.
A potent competitive inhibitor. (correct answer)
A typical uncompetitive inhibitor.
An irreversible covalent inhibitor.

Explanation: When analyzing enzyme inhibition, you need to consider three key factors: the inhibitor's structure relative to the substrate, where it binds, and whether substrate concentration can overcome the inhibition. Methotrexate demonstrates classic competitive inhibition characteristics. As a structural analog of dihydrofolate, it mimics the natural substrate's shape, allowing it to bind directly to the enzyme's active site. The crucial clue is that increasing dihydrofolate concentration can restore maximal reaction velocity - this is the hallmark of competitive inhibition. When substrate concentration becomes high enough, it can outcompete the inhibitor for the active site, eventually achieving normal

V_{max}

. Looking at the incorrect options: A) Noncompetitive inhibitors bind to allosteric sites, not the active site, and increasing substrate concentration cannot restore

V_{max}

. Since methotrexate binds to the active site and substrate can overcome inhibition, this doesn't fit. C) Uncompetitive inhibitors only bind to the enzyme-substrate complex, not the free enzyme. The question describes binding to the enzyme's active site, indicating direct competition with substrate. D) Irreversible covalent inhibitors form permanent bonds with the enzyme. However, the ability to restore activity by increasing substrate concentration indicates the inhibition is reversible. The 1000-fold higher affinity simply makes methotrexate a particularly potent competitive inhibitor, not a different type of inhibition. Remember: if an inhibitor is a structural analog that binds the active site and can be overcome by excess substrate, think competitive inhibition first.

Question 5

An enzyme's kinetic parameters were measured in the absence and presence of an inhibitor. In the absence of the inhibitor, $K_m = 15 \mu M$ and $k_{cat} = 200 s^{-1}$ . In the presence of a 50 nM concentration of the inhibitor, the apparent $K_m = 15 \mu M$ and the apparent $k_{cat} = 50 s^{-1}$ . Based on these data, what is the mechanism of inhibition?

Competitive, because the inhibitor increases the apparent affinity of the enzyme for the substrate.
Uncompetitive, because both the maximal velocity and the apparent $K_m$ are decreased.
Mixed, because the inhibitor affects the catalytic rate but has a different affinity for E and ES.
Noncompetitive, because the inhibitor reduces the catalytic rate without affecting substrate binding to the active site. (correct answer)

Explanation: The data show that the apparent

K_m

is unchanged (15 μM) while the apparent

k_{cat}

, which determines

V_{max}

, is decreased (from 200 to 50 s⁻¹). This specific kinetic signature—a decrease in

V_{max}

with no change in

K_m

—is characteristic of pure noncompetitive inhibition. This occurs when the inhibitor binds with equal affinity to the free enzyme (E) and the enzyme-substrate complex (ES), affecting catalysis but not the apparent substrate binding.

Question 6

For a mixed inhibitor, the dissociation constant for inhibitor binding to the free enzyme is $K_I$ , and for binding to the enzyme-substrate complex is $K_I'$ . If kinetic analysis reveals that $K_I < K_I'$ , what are the expected effects on the enzyme's kinetic parameters?

Apparent $K_m$ increases and apparent $V_{max}$ decreases. (correct answer)
Apparent $K_m$ decreases and apparent $V_{max}$ decreases.
Apparent $K_m$ is unchanged and apparent $V_{max}$ decreases.
Apparent $K_m$ increases and apparent $V_{max}$ is unchanged.

Explanation: The condition

K_I < K_I'

means the inhibitor has a higher affinity (binds more tightly) to the free enzyme (E) than to the enzyme-substrate complex (ES). Binding to free E effectively removes it from the pool available to bind substrate, which resembles competitive inhibition. This component increases the apparent

K_m

. Since it is a mixed inhibitor, it also binds ES and reduces the catalytic rate, causing a decrease in apparent

V_{max}

Question 7

Two reversible inhibitors, Compound A and Compound B, are analyzed. At low substrate concentrations, both compounds reduce the reaction rate. At very high, saturating substrate concentrations, the rate in the presence of Compound A approaches the uninhibited $V_{max}$ , while the rate in the presence of Compound B remains significantly depressed. What can be concluded?

Compound A is competitive, while Compound B could be noncompetitive or uncompetitive. (correct answer)
Compound A is uncompetitive, while Compound B is competitive.
Both compounds are competitive, but Compound B has a much lower $K_I$ .
Compound A is noncompetitive, while Compound B is an irreversible inhibitor.

Explanation: The ability to overcome inhibition by increasing substrate concentration is the defining characteristic of competitive inhibition. Since the effect of Compound A is overcome at high [S], it must be a competitive inhibitor. Inhibition that persists at high [S] indicates that

V_{max}

has been lowered. Both noncompetitive and uncompetitive inhibitors lower

V_{max}

. Therefore, Compound B belongs to one of these classes.

Question 8

An enzyme is simultaneously treated with a competitive inhibitor (Drug X) and an uncompetitive inhibitor (Drug Y). What will be the net effect on the enzyme's apparent $K_m$ and apparent $V_{max}$ ?

Apparent $V_{max}$ will decrease, and the effect on apparent $K_m$ is unpredictable without more information. (correct answer)
Apparent $V_{max}$ will be unchanged, and apparent $K_m$ will increase.
Apparent $V_{max}$ will decrease, and apparent $K_m$ will also decrease.
Both apparent $V_{max}$ and apparent $K_m$ will increase.

Explanation: The competitive inhibitor (X) increases apparent

K_m

and does not affect

V_{max}

. The uncompetitive inhibitor (Y) decreases both apparent

K_m

and apparent

V_{max}

. When combined, only Drug Y affects

V_{max}

, so the apparent

V_{max}

will definitively decrease. However, the two drugs have opposing effects on apparent

K_m

. The final value will depend on the relative concentrations and binding affinities (

K_I

) of the two inhibitors, making the net effect on

K_m

unpredictable.

Question 9

An investigator analyzes an enzyme inhibitor using a Lineweaver-Burk plot (1/v vs. 1/[S]). The resulting plot shows a series of lines that intersect at the same point on the y-axis, but have different slopes and x-intercepts. This pattern is characteristic of what type of inhibition?

Competitive inhibition. (correct answer)
Noncompetitive inhibition.
Uncompetitive inhibition.
Irreversible inhibition.

Explanation: On a Lineweaver-Burk plot, the y-intercept is equal to 1/

V_{max}

. If the lines for the uninhibited and inhibited reactions intersect on the y-axis, it means that the y-intercept is the same for all inhibitor concentrations, and therefore

V_{max}

is unchanged. A change in the slope (

K_m

V_{max}

) and x-intercept (-1/

K_m

) with a constant

V_{max}

is the defining kinetic signature of competitive inhibition.

Question 10

Which of the following statements provides a valid reason why a pure noncompetitive inhibitor decreases the apparent $V_{max}$ of an enzymatic reaction?

The inhibitor binds to the active site, preventing the substrate from binding and thus lowering the effective enzyme concentration.
The inhibitor binds to the enzyme-substrate complex, shifting the reaction equilibrium away from product formation.
The inhibitor binds to an allosteric site on both E and ES, effectively removing a fraction of the enzyme from catalysis regardless of substrate concentration. (correct answer)
The inhibitor increases the apparent $K_m$ so dramatically that the enzyme can never reach its theoretical maximal velocity.

Explanation: A pure noncompetitive inhibitor binds to an allosteric site with equal affinity for both the free enzyme (E) and the enzyme-substrate complex (ES). This binding does not prevent substrate binding but it renders the enzyme catalytically inactive. Thus, it effectively lowers the concentration of functional enzyme ([E]T), which directly leads to a decrease in the apparent

V_{max}

(since

V_{max} = k_{cat}[E]_T

). This effect cannot be overcome by high substrate concentration.

Question 11

An enzyme is subject to feedback inhibition by the final product of its metabolic pathway. The product has no structural similarity to the enzyme's substrate. Kinetically, the inhibitor is found to decrease $V_{max}$ and increase the apparent $K_m$ . This product is functioning as which type of inhibitor?

Competitive inhibitor.
Noncompetitive inhibitor.
Uncompetitive inhibitor.
Mixed inhibitor. (correct answer)

Explanation: The lack of structural similarity and the nature of feedback regulation strongly suggest binding to an allosteric site, ruling out simple competitive inhibition. The kinetic data show a decrease in

V_{max}

and an increase in apparent

K_m

. This specific combination of effects is characteristic of mixed inhibition (specifically, the case where the inhibitor has a higher affinity for the free enzyme than for the ES complex).

Question 12

If an inhibitor can be completely displaced from an enzyme by adding a very large excess of substrate, which of the following must be true about the inhibitor and the enzyme's kinetic parameters in its presence?

The inhibitor is noncompetitive, and the apparent $K_m$ is unchanged.
The inhibitor is competitive, and the apparent $V_{max}$ is unchanged. (correct answer)
The inhibitor is uncompetitive, and the apparent $K_m$ is decreased.
The inhibitor is mixed, and the apparent $V_{max}$ is decreased.

Explanation: When you encounter enzyme inhibition problems, focus on the key clue: whether excess substrate can displace the inhibitor. This tells you about the binding mechanism and predicts specific kinetic effects. If a large excess of substrate can completely displace an inhibitor, the inhibitor must be competing with the substrate for the same binding site—the enzyme's active site. This is the definition of competitive inhibition. In competitive inhibition, the inhibitor and substrate cannot bind simultaneously because they occupy the same location. When competitive inhibition occurs, it appears harder for the substrate to bind (increasing apparent

K_m

), but once substrate does bind, the enzyme functions normally. Therefore,

V_{max}

remains unchanged because at saturating substrate concentrations, virtually all inhibitor is displaced and the enzyme reaches its full catalytic potential. Answer A incorrectly describes noncompetitive inhibition, where the inhibitor binds to a different site than the substrate. In this case, excess substrate cannot displace the inhibitor, and

K_m

typically remains unchanged while

V_{max}

decreases. Answer C describes uncompetitive inhibition, where the inhibitor only binds to the enzyme-substrate complex. Here, substrate cannot displace the inhibitor either, and

K_m

actually decreases. Answer D refers to mixed inhibition, a combination mechanism where the inhibitor affects both

K_m

and

V_{max}

, but again, substrate excess cannot fully displace it. Study tip: Remember the displacement test—only competitive inhibitors can be overcome by excess substrate because they compete for the same binding site.

Question 13

An enzyme follows Michaelis-Menten kinetics with $K_m = 2.0$ mM and $V_{max} = 100$ μmol/min. In the presence of inhibitor X at 5 mM concentration, the apparent $K_m$ increases to 6.0 mM while $V_{max}$ remains 100 μmol/min. What is the inhibition constant ( $K_i$ ) for inhibitor X?

2.5 mM (correct answer)
5.0 mM
7.5 mM
10.0 mM

Explanation: This is competitive inhibition since

K_m

increases while

V_{max}

remains constant. For competitive inhibition:

K_m^{app} = K_m(1 + [I]/K_i)

. Substituting:

6.0 = 2.0(1 + 5.0/K_i)

. Solving:

3.0 = 1 + 5.0/K_i

, so

2.0 = 5.0/K_i

, therefore

K_i = 2.5

mM. Choice B incorrectly assumes

K_i = [I]

. Choice C results from algebraic error (adding instead of subtracting 1). Choice D comes from incorrect formula manipulation.

Question 14

A pharmaceutical company is developing a drug that acts as a reversible inhibitor of enzyme X. They observe that increasing substrate concentration can completely overcome the inhibition at any inhibitor concentration. However, when they examine the inhibition pattern more closely, they find that very high substrate concentrations are required to achieve complete reversal, much higher than predicted by simple competitive inhibition theory. What is the most likely explanation?

The inhibitor shows pure competitive inhibition but has extremely high binding affinity (very low $K_i$ )
The inhibitor exhibits mixed inhibition with strong competitive character ( $K_{is} << K_{ii}$ ) (correct answer)
The enzyme shows negative cooperativity that interferes with normal competitive inhibition kinetics
The inhibitor causes partial uncompetitive inhibition that becomes competitive at high substrate concentrations

Explanation: Mixed inhibition with

K_{is} << K_{ii}

appears nearly competitive because the inhibitor binds much more weakly to ES complex. However, some inhibitor still binds to ES, requiring higher substrate concentrations than pure competitive inhibition to achieve complete reversal. Choice A would show normal competitive behavior. Choice C doesn't explain the inhibition pattern. Choice D incorrectly describes uncompetitive inhibition, which cannot be overcome by substrate.

Question 15

During the development of an enzyme inhibitor, researchers observe that the inhibition can be reversed by washing the enzyme, but the reversal kinetics are extremely slow (half-life > 2 hours). Additionally, the inhibition pattern shows characteristics of mixed inhibition with very low apparent $K_i$ values. What type of inhibition is most likely occurring?

Reversible mixed inhibition with extremely high binding affinity due to multiple weak interactions
Competitive inhibition complicated by slow substrate binding kinetics in the assay conditions
Irreversible covalent modification that appears reversible due to slow enzyme turnover
Slow-binding inhibition involving induced fit conformational changes in the enzyme-inhibitor complex (correct answer)

Explanation: When analyzing enzyme inhibition kinetics, pay close attention to the combination of reversibility characteristics and time-dependent behavior. This question tests your understanding of slow-binding inhibition, a special case where initial binding is followed by a slow conformational change. The key evidence pointing to slow-binding inhibition includes: the extremely slow reversal kinetics (half-life > 2 hours), complete reversibility upon washing, mixed inhibition pattern, and very low apparent

K_i

values. In slow-binding inhibition, the inhibitor first binds rapidly to form an initial complex, then undergoes a slow conformational rearrangement to form a much tighter, more stable complex. This explains both the high apparent affinity (low

K_i

) and the slow dissociation kinetics. Option A is incorrect because standard reversible inhibition, even with high affinity, wouldn't show such dramatically slow reversal kinetics. The binding and unbinding rates would be much faster. Option B is wrong because competitive inhibition wouldn't produce a mixed inhibition pattern, and slow substrate binding wouldn't affect inhibitor dissociation rates during washing when no substrate is present. Option C is incorrect because truly irreversible covalent modification wouldn't be reversible by simple washing, regardless of enzyme turnover rates. Remember that slow-binding inhibition is characterized by time-dependent inhibition that appears much tighter than initial rapid equilibrium measurements suggest. Look for the combination of reversibility, slow kinetics, and unusually tight apparent binding - these are hallmarks of conformational changes stabilizing the enzyme-inhibitor complex.

Question 16

An allosteric enzyme with two identical subunits binds substrate cooperatively. Inhibitor Z appears to bind to only one subunit at a time, never to both simultaneously. When both substrate and inhibitor are present, three main species are observed: free enzyme (E), enzyme with substrate on both subunits (ES₂), and enzyme with substrate on one subunit and inhibitor on the other (ESI). Based on this binding pattern, what kinetic behavior would be expected?

Pure competitive inhibition since substrate and inhibitor compete for the same binding sites
Uncompetitive inhibition since the inhibitor can only bind after substrate binding occurs
Mixed inhibition with unusual concentration dependence due to the asymmetric binding constraint (correct answer)
Noncompetitive inhibition with reduced cooperativity due to inhibitor binding to free subunits

Explanation: The asymmetric binding creates a complex mechanism where inhibitor affects both free enzyme (reducing substrate binding) and ES complex (preventing formation of ES₂), characteristic of mixed inhibition. The constraint that inhibitor binds only to one subunit creates unusual concentration dependencies not seen in simple mixed inhibition. Choice A ignores the ESI complex formation. Choice B is incorrect since inhibitor can bind to free enzyme. Choice D doesn't account for the mixed binding pattern described.

Question 17

A multi-subunit enzyme shows positive cooperativity for substrate binding. When inhibitor Q is added, the Hill coefficient decreases from 2.8 to 1.9, the apparent $K_{0.5}$ increases, but the maximum velocity remains unchanged. Which mechanism best explains these observations?

Competitive inhibition that disrupts positive cooperativity by binding to the same site as substrate
Uncompetitive inhibition that selectively targets highly cooperative enzyme-substrate complexes
Mixed inhibition with preferential binding to the low-affinity conformational state
Allosteric inhibition that reduces cooperativity without affecting the catalytic mechanism (correct answer)

Explanation: When you encounter questions about enzyme cooperativity and inhibition mechanisms, focus on how the Hill coefficient and kinetic parameters change together to reveal the underlying mechanism. This enzyme shows positive cooperativity (Hill coefficient = 2.8), meaning subunits communicate to enhance substrate binding. When inhibitor Q is added, three key changes occur: the Hill coefficient drops to 1.9,

K_{0.5}

increases, and

V_{max}

stays constant. This pattern points to reduced cooperativity without affecting the catalytic machinery itself. Answer D correctly identifies allosteric inhibition that reduces cooperativity. The inhibitor binds to an allosteric site (not the active site), disrupting the cooperative communication between subunits. This explains why cooperativity decreases (lower Hill coefficient) and why more substrate is needed for half-maximal binding (higher

K_{0.5}

). Since the active sites remain unaffected,

V_{max}

stays unchanged. Answer A is wrong because competitive inhibition would show changed

K_{0.5}

but typically wouldn't dramatically alter cooperativity patterns. Answer B incorrectly describes uncompetitive inhibition, which would decrease

V_{max}

since it removes enzyme-substrate complexes from the catalytic cycle. Answer C describes mixed inhibition, which would also typically affect

V_{max}

due to binding at the active site. Remember this pattern: when you see decreased cooperativity (lower Hill coefficient) with unchanged

V_{max}

but altered binding affinity, think allosteric effects that disrupt subunit communication without touching the catalytic mechanism.

Question 18

Researchers studying enzyme kinetics obtain the following data: without inhibitor, $K_m = 4$ mM and $V_{max} = 80$ μmol/min. With 2 mM inhibitor, $K_m^{app} = 2$ mM and $V_{max}^{app} = 40$ μmol/min. If this represents mixed inhibition, what can be concluded about the relative binding affinities?

$K_{is} = 2$ mM and $K_{ii} = 2$ mM, indicating equal binding affinity to both forms
$K_{is} = 4$ mM and $K_{ii} = 2$ mM, indicating stronger binding to enzyme-substrate complex (correct answer)
$K_{is} = 2$ mM and $K_{ii} = 4$ mM, indicating stronger binding to free enzyme
$K_{is} = 1$ mM and $K_{ii} = 6$ mM, indicating much stronger binding to free enzyme

Explanation: For mixed inhibition:

K_m^{app} = K_m \frac{1 + [I]/K_{is}}{1 + [I]/K_{ii}}

and

V_{max}^{app} = \frac{V_{max}}{1 + [I]/K_{ii}}

. From

V_{max}

data:

40 = 80/(1 + 2/K_{ii})

, so

K_{ii} = 2

mM. From

K_m

data:

2 = 4 \frac{1 + 2/K_{is}}{1 + 2/2} = 4 \frac{1 + 2/K_{is}}{2}

, solving gives

K_{is} = 4

mM. Since

K_{ii} < K_{is}

, the inhibitor binds more tightly to ES complex. Other choices contain calculation errors.

Question 19

Enzyme Y catalyzes the reaction A → B and exhibits sigmoidal kinetics due to cooperativity. When inhibitor Z is added, the enzyme still shows sigmoidal behavior, but both the apparent $K_m$ and $V_{max}$ decrease proportionally by the same factor. Based on these observations, what type of inhibition is most likely occurring?

Pure competitive inhibition affecting multiple binding sites simultaneously
Pure noncompetitive inhibition with the inhibitor binding to an allosteric site
Uncompetitive inhibition where the inhibitor binds only to the enzyme-substrate complex (correct answer)
Mixed inhibition with equal affinity for free enzyme and enzyme-substrate complex

Explanation: Uncompetitive inhibition decreases both

K_m

and

V_{max}

by the same factor because the inhibitor only binds to ES complex, removing it from the reaction pathway. This maintains the sigmoidal shape while shifting the curve. Choice A is incorrect because competitive inhibition increases

K_m

. Choice B is wrong because pure noncompetitive inhibition decreases only

V_{max}

, not

K_m

. Choice D is incorrect because mixed inhibition typically affects

K_m

and

V_{max}

by different factors.

Question 20

A researcher is developing a drug that functions as an uncompetitive inhibitor for a specific enzyme. In which scenario would this drug be expected to have the highest efficacy?

When cellular concentrations of the enzyme's substrate are significantly below the $K_m$ .
When cellular concentrations of the enzyme's substrate are near the $K_m$ .
When cellular concentrations of the enzyme's substrate are significantly above the $K_m$ . (correct answer)
When the enzyme concentration is significantly higher than the substrate concentration.

Explanation: Uncompetitive inhibitors bind exclusively to the enzyme-substrate (ES) complex. The concentration of the ES complex is highest when the substrate concentration is high and saturating (significantly above the

K_m

). Therefore, an uncompetitive inhibitor will be most effective under these conditions, as its target (the ES complex) is most abundant.